Comparative Cost-Effectiveness of Plerixafor Plus Granulocyte-Colony Stimulating Factor Versus Cyclophosphamide Plus Granulocyte-Colony Stimulating Factor for Autologous Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma

Comparative Cost ◽

Cell Mobilization ◽

Comparative Cost-Effectiveness Of Plerixafor Plus Granulocyte-Colony Stimulating Factor Versus Cyclophosphamide Plus Granulocyte-Colony Stimulating For Autologous Peripheral Blood Stem Cell Mobilization In Patients With Non-Hodgkin's Lymphoma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2009.12.160 ◽

2010 ◽

Vol 16 (2) ◽

pp. S206 ◽

Cited By ~ 6

Author(s):

C.J. Campen ◽

E.P. Armstrong ◽

J.A. Christian ◽

S. Hadeed ◽

A.M. Yeager

Keyword(s):

Stem Cell ◽

Cost Effectiveness ◽

Peripheral Blood ◽

Factor Versus ◽

Comparative Cost ◽

Cell Mobilization ◽

Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma

Leukemia & Lymphoma ◽

10.1080/10428194.2017.1324161 ◽

2017 ◽

Vol 59 (1) ◽

pp. 42-48 ◽

Cited By ~ 4

Author(s):

Giuseppe Milone ◽

Massimo Martino ◽

Salvatore Leotta ◽

Andrea Spadaro ◽

Valentina Zammit ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cost Effectiveness ◽

Peripheral Blood ◽

On Demand ◽

Cell Mobilization ◽

Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients

Cytotherapy ◽

10.1016/j.jcyt.2015.05.010 ◽

2015 ◽

Vol 17 (10) ◽

pp. 1485-1493 ◽

Cited By ~ 16

Author(s):

Massimo Martino ◽

Anna Grazia Recchia ◽

Tiziana Moscato ◽

Roberta Fedele ◽

Santo Neri ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Peripheral Blood ◽

Factor Versus ◽

De Novo ◽

Cell Mobilization ◽

Pegylated granulocyte-colony stimulating factor versus non-pegylated granulocyte-colony stimulating factor for peripheral blood stem cell mobilization: A systematic review and meta-analysis

Journal of Clinical Apheresis ◽

10.1002/jca.21550 ◽

2017 ◽

Vol 32 (6) ◽

pp. 517-542 ◽

Cited By ~ 8

Author(s):

Jew W. Kuan ◽

Anselm T. Su ◽

Chooi F. Leong

Keyword(s):

Systematic Review ◽

Stem Cell ◽

Peripheral Blood ◽

Factor Versus ◽

Meta Analysis ◽

Cell Mobilization ◽

Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2012.01.005 ◽

2012 ◽

Vol 18 (7) ◽

pp. 1128-1135 ◽

Cited By ~ 41

Author(s):

Mehdi Hamadani ◽

S. Thomas Kochuparambil ◽

Salman Osman ◽

Aaron Cumpston ◽

Sonia Leadmon ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Peripheral Blood ◽

Low Dose ◽

Cell Mobilization ◽

Stimulating Factor ◽

Intermediate Dose

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

Haematologica ◽

10.3324/haematol.2012.071456 ◽

2012 ◽

Vol 98 (2) ◽

pp. 172-178 ◽

Cited By ~ 30

Author(s):

N. Russell ◽

K. Douglas ◽

A. D. Ho ◽

M. Mohty ◽

K. Carlson ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Steady State ◽

Peripheral Blood ◽

First Line ◽

Cell Mobilization ◽

Faculty Opinions recommendation of Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958946.793462992 ◽

2012 ◽

Author(s):

Nicolas Mounier

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Steady State ◽

Peripheral Blood ◽

First Line ◽

Cell Mobilization ◽

Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma

Transfusion and Apheresis Science ◽

10.1016/j.transci.2020.102844 ◽

2020 ◽

Vol 59 (5) ◽

pp. 102844

Author(s):

Muzaffer Keklik ◽

Esen Karakus ◽

Leylagul Kaynar ◽

Gulsah Akyol ◽

Zeynep Tugba Guven ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Peripheral Blood ◽

Low Dose ◽

Stem Cell Mobilization ◽

Cell Mobilization ◽

Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2020.12.009 ◽

2021 ◽

Author(s):

Beatrice Anna Zannetti ◽

Francesco Saraceni ◽

Claudia Cellini ◽

Elisabetta Fabbri ◽

Federica Monaco ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Retrospective Study ◽

Low Dose ◽

Stem Cell Mobilization ◽

High Dose ◽

Cell Mobilization ◽

Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency*

Leukemia & Lymphoma ◽

10.1080/10428194.2016.1239261 ◽

2016 ◽

Vol 58 (5) ◽

pp. 1123-1129 ◽

Cited By ~ 6

Author(s):

Adebayo Ogunniyi ◽

Mabel Rodriguez ◽

Sean Devlin ◽

Nelly Adel ◽

Heather Landau ◽

...

Keyword(s):

Risk Factors ◽

Multiple Myeloma ◽

Stem Cell ◽

Collection Efficiency ◽

Factors Associated ◽

Cell Mobilization ◽

Stimulating Factor ◽

Stem Cell Collection